Atlas Translational PhD Program

ATLAS - Joint PhD Program from BioNTech and TRON


ATLAS is an international graduate program with a strong focus on translational medicine. ATLAS covers immunotherapy, computational biology, infectious diseases, cardiovascular, aging and regenerative biomedicine.

Call for applications is open until October 7th, 2024.

Apply now!

ATLAS our Talent Academy for TransLAtional Science, guides and supports PhD students to conduct excellent research projects and offers comprehensive training in cutting-edge technologies. In addition, we ensure that you learn the transferable skills needed for a successful career in academia or industry. Scientific training within the program has a strong focus on "the art of translation", i.e. turning basic scientific discoveries into applications.

Özlem Türeci and Uğur Şahin: BioNTech and TRON founders and professors at University Medical Center, Mainz, Germany
TRON technician working on Illumina NovaSeq, an instrument used for Next Generation Sequencing

The main research topics at ATLAS evolve around:

  • Immunotherapy of cancer, infectious diseases & autoimmunity

  • Cardiovascular, aging & regenerative biomedicine

  • RNA biochemistry

  • Protein engineering

  • Bioinformatics & systems biology

  • Biomarker research

  • Antimicrobial therapies

>60
PhD Students
30%
International
14
Nationalities

we welcome applications from all over the world